Biguanide Market 2021 Growth, COVID Impact, Trends Analysis Report 2027
The biguanide drugs market is anticipated to grow at a considerable CAGR of more than 7.0% during the forecast period 2020-2026. Metformin IR (immediate release) and Metformin ER (Extended-release) are the most common biguanide in the global market. The growth in the patient pool of type 2 diabetes, increasing diagnosis rate in the emerging economies, increasing healthcare expenditure by individuals are some of the major factors which provide a significant opportunity for the companies to enter the market. As per the International Diabetes Federation (IDF), the global prevalence of diabetes in the age group of 20-79 years was 463 million in 2019. The number is expected to reach 578 million by 2030. A large share of this patient pool will be in emerging economies of Asia-Pacific, Latin America, and Middle East & Africa. (Get 15% Discount on Buying this Report) Get Report Sample Copy @ https://www.omrglobal.com/request-sample/biguanide-market Some of t...